BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Santhera Announces Publication by ReveraGen of Positive Phase IIa-Extension Study Results with Vamorolone in Patients with Duchenne Muscular Dystrophy

  Santhera Pharmaceuticals announces publication by ReveraGen of positive study data with vamorolone in patients with Duchenne muscular dystrophy.

  August 27, 2019

   · 

  8 min read
• 

  Policy

  The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing

  The Alliance for Regenerative Medicine released a Therapeutic Developers’ Statement of Principles, setting forth a bioethical framework for the use of gene editing in therapeutic applications.

  August 27, 2019

   · 

  5 min read
• 

  Deals

  Sareum Holdings plc - Pre-Close Trading Update for 27 August 2019

  The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014

  August 27, 2019

   · 

  9 min read
• 

  Business

  Vaccitech Appoints Bill Enright as New Chief Executive Officer

  Vaccitech announced that it has appointed Bill Enright as its new Chief Executive Officer.

  August 27, 2019

   · 

  2 min read
• 

  Policy

  Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

  Pharmaceutical manufacturing license and GMP compliance of the Rentschler Fill Solutions plant reconfirmed by the Austrian Agency for Health and Food Safety (AGES)

  August 27, 2019

   · 

  2 min read
• 

  Business

  Velabs Therapeutics Enters into a Screening Cooperation with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening After Successful Feasibility Study

  Velabs Therapeutics announced that its cooperation with Chiome Bioscience, Inc., Tokyo, will be deepened, to jointly discover modulatory and functional antibodies for one of Chiome’s GPCR target genes.

  August 27, 2019

   · 

  3 min read
• Policy

  Local Health Department Approaches to Opioid Use Prevention and Response Featured in New NACCHO Survey

  Local Health Departments in Colorado, Kentucky, Maine, Maryland, Massachusetts, Minnesota, Missouri, Nevada, New Hampshire, Ohio, Pennsylvania, Tennessee, and Wisconsin Tell Their Stories

  August 27, 2019

   · 

  4 min read